AV8 / AT-8708 is an innovative activator solution used to generate high purity chlorine dioxide (ClO2) using Accepta’s high-performance Activ-Ox chlorine dioxide generating system.
AV8 / AT-8708 is used in conjunction with Activ-Ox pre-cursors and the Activ-Ox dosing system.
AV8 / AT-8708 is a specially formulated dilute acid solution approved by the UK Drinking Water Inspectorate. It is used in conjunction with Accepta AX10 / AT-8710 or AX20 / AT-8720 to release the ‘active oxygen’ disinfecting power of chlorine dioxide.
AV8 / AT-8708 is much safer than other strong acid activators used with so-called ‘stabilised chlorine dioxide’ solutions and is classified as non-hazardous according to the CHIP Regulations.
- Innovative activator solution used to generate high purity chlorine dioxide
- Specially formulated dilute acid solution
- Approved by the UK Drinking Water Inspectorate
- Much safer than other strong acid activators
- Easy to transport, classified as non-hazardous according to the CHIP Regulations
|Colour:||Clear colourless to pale straw|
|Solubility in water:||Complete|
*Full details of the product properties are available in the Safety Data Sheet. See below.
Application & Dosage Information
AV8 / AT-8708 should be dosed at the same rate as AV10 / AT-8710 or AX20 / AT-8720 and used strictly in accordance with the recommendations of your Accepta technical consultant.
AV8 / AT-8708 and Pre-cursor products should never be mixed neat and where the continuous application of chlorine dioxide is required an Activ-Ox chlorine dioxide generating system should be used.
For further technical assistance concerning dosage rates for AV8 / AT-8708 please contact Accepta technical support.
It is always advisable to carry out a ‘Control Of Substances Hazardous to Health’ (COSHH) assessment before use.
Safety, Storage & Handling
For full details concerning safety precautions, storage and handling procedures for this product please refer to the latest Safety Data Sheet. To request the latest MSDS for this product please fill out the form below.